RC

Rockmore Capital

North America, New York, United States, New York

Description

Rockmore Capital is an investment advisory firm that is headquartered in New York, United States.

Investor Profile

Rockmore Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rockmore Capital frequently co-invest with?

DC
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 2
OP
North America, New York, United States, New York
Co-Investments: 1
Rosalind Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
BC
North America, New York, United States, New York
Co-Investments: 1
KC
Europe, England, United Kingdom, London
Co-Investments: 1
Leadiant Biosciences
North America, Maryland, United States, Gaithersburg
Co-Investments: 1

What are some of recent deals done by Rockmore Capital?

Soligenix

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownJul 2, 2010
Amount Raised: $5,904,277
CEL-SCI

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 20, 2009
Amount Raised: $4,400,000